Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-30

Clinical Trial Update: A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates AMDX-2011P for primary open-angle glaucoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMDX-2011P

Snippet

Sponsor: Amydis Inc. | Conditions: Primary Open Angle Glaucoma | Phase 2 | Status: RECRUITING